Sharemaestro Newsreel

ResMed Inc. (NYSE: RMD) grows FY 2026 revenue to $5,653M and lifts dividend

ResMed Inc. reported strong financial results for fiscal year 2026 and the fourth quarter, with annual revenue increasing 10% to $5,653 million and non-GAAP diluted EPS rising 17% to $11.17. The company also announced a 10% increase in its quarterly cash dividend to $0.66 …

Nyxoah SA (NYXH) (Q2 2026) Earnings Call Highlights: US Revenue Surges 22% Sequentially, $110M ...

Nyxoah SA (NYXH) reported strong Q2 2026 results, with US revenue surging 22% sequentially to EUR5.2 million and international revenue growing 19%. The company secured $110 million in financing, doubling its active US account base and increasing trained surgeons. Despite significant operating losses, Nyxoah …

Average basic shares outstanding of Nyxoah SA – TURQUOISE:NYXHB

This article provides financial information for Nyxoah SA (TURQUOISE:NYXHB), specifically detailing its average basic shares outstanding. The content is presented as a financial data point within a TradingView context, indicating market data and company financials for investors.

Resmed director Peter C. Farrell sells $1.8m in stock By Investing.com

ResMed director Peter C. Farrell sold 8,000 shares of company common stock for $1.8 million on August 5, 2026, under a Rule 10b5-1 trading plan. This transaction leaves him with 52,773 shares directly held. The sale occurred as ResMed's stock has declined by approximately …

Pulse Biosciences earnings on deck as PFA technology faces test By Investing.com

Pulse Biosciences Inc. is expected to report its second-quarter results after market close on Thursday, with investors keenly watching the performance of its Nanosecond Pulsed Field Ablation (PFA) technology. Analysts anticipate a loss of 29 cents per share on revenue of $533,330, reflecting sequential …

Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?

AngioDynamics (ANGO) faces a trade-off between its rapidly expanding Med Tech platforms and persistent margin pressure from tariffs and rising operating costs. While NanoKnife, Auryon, and AlphaVac show strong growth potential and strategic importance, the company's valuation is mixed, and a Zacks Rank #4 …

Merit Medical Systems (MMSI) COO Neil Peterson Sells 21,449 Shares

Merit Medical Systems (MMSI) COO Neil Peterson sold 21,449 shares of the company for approximately $1.82 million, reducing his direct ownership to 25,551 shares. This sale is part of a broader insider selling trend, with 9 insider sells versus 5 buys over the past …

OraSure Announces Second Quarter 2026 Financial Results

OraSure Technologies, Inc. (OSUR) reported its financial results for the second quarter of 2026. The company announced its performance during this period, which is a key indicator of its operational health and market standing. This update provides investors and stakeholders with crucial insights into …

Dental company Envista reports 5% core sales growth in Q2

Envista Holdings Corporation (NYSE: NVST) reported strong second-quarter 2026 results, achieving 5.0% core sales growth and a 58% year-over-year increase in adjusted diluted EPS. The company raised its full-year 2026 guidance for core sales growth, adjusted EBITDA growth, and adjusted EPS, reflecting confidence in …

Earnings call transcript: Envista tops Q2 2026 estimates and raises outlook

Envista Holdings (NVST) exceeded Wall Street expectations for Q2 2026, reporting adjusted earnings of $0.41 per share on revenue of $730.5 million, surpassing analyst estimates. The company raised its full-year 2026 guidance, citing strong performance across its dental portfolio, increased margins, and robust free …

West Pharmaceutical Services declares Q3 2026 distribution of R$ 0.02 per unit

West Pharmaceutical Services has announced a Q3 2026 cash distribution of R$ 0.02 per unit (ISIN BRW2STBDR007). Shares will trade with entitlement through July 27, 2026, and the payment is scheduled for August 11, 2026. The announcement notes that this news brief was generated …

Dentsply Sirona investors brace for earnings amid Medline threat By Investing.com

Dentsply Sirona Inc. is preparing to report second-quarter earnings, facing investor scrutiny over its ability to counter competitive pressure from Medline's expansion into the dental market. Analysts forecast earnings of 35 cents per share and revenue of $889.2 million, representing a significant year-over-year decline. …

Innovative Eyewear Inc (LUCY) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Innovative Eyewear Inc (LUCY), detailing its current earnings forecast score, price target, and analyst ratings. Based on one analyst, the stock has a "Hold" rating with a target price of $3.00. The company's expected revenue for the …

Polen Touts ‘New BD,’ Product Innovation As Company Raises 2026 Earnings Outlook

Polen, representing BD (Becton, Dickinson and Company), is highlighting a "New BD" focus and significant product innovation. This strategic shift and new developments have led the company to raise its earnings outlook for 2026. The article indicates a positive financial forecast driven by these …

What Drove Warby Parker (NYSE:WRBY) Stock Higher?

Teleflex Q2 2026 slides: mixed results amid integration challenges

Teleflex reported mixed Q2 2026 results with strong performance in Vascular and Surgical segments, but challenges in integrating its Interventional business led to a reduced revenue outlook. Despite lower revenue guidance, the company raised its adjusted EPS guidance due to share repurchases and lower …

Kestra Medical Technologies CFO Mahboob sells $172,633 of common shares

Kestra Medical Technologies CFO Vaseem Mahboob sold 6,995 common shares in two transactions on August 4, 2026, totaling $172,633. One sale covered tax withholding for restricted stock, and the other was under a Rule 10b5-1 plan. Despite the sales, Mahboob still owns 86,896 shares, …

ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?

AngioDynamics (ANGO) shares have significantly outperformed the market, gaining 33.5% in three months, driven by its shift towards higher-margin Med Tech platforms like NanoKnife and Auryon. While Med Tech growth and product differentiation support the company's momentum, concerns about valuation, tariff impact on earnings …

KORU Medical Systems, Inc. Stock 12‑Month Price Target Cut to $6.6, Implies 60% Upside

Analysts have slightly reduced the 12-month average price target for KORU Medical Systems, Inc. (KRMD) stock from $6.8 to $6.6, implying a 60% potential upside based on the Aug. 5 closing price. The consensus rating among 5 analysts remains a "Buy," with 4 analysts …

LeMaitre Vascular To Go Ex-Dividend On August 20th, 2026 With 0.25 USD Dividend Per Share

LeMaitre Vascular is scheduled to go ex-dividend on August 20th, 2026. The company will be distributing a dividend of $0.25 per share to its shareholders. Investors wishing to receive this dividend should ensure they own shares before the ex-dividend date.

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

LeMaitre Vascular, Inc. announced its participation in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026, where management will hold investor meetings. The company, a provider of devices for peripheral vascular disease, aims to connect with investors regarding its …

Align Technology Inc. stock underperforms Thursday when compared to competitors

Align Technology Inc. (ALGN) stock declined by 3.29% to $169.08 on Thursday, underperforming the broader market. This drop occurred during a session where the S&P 500 Index fell 0.18% and the Dow Jones Industrial Average dropped 0.85%, ending a three-day winning streak for the …

Baxter International Inc. stock underperforms Thursday when compared to competitors

Baxter International Inc. (BAX) shares fell 1.17% on Thursday, closing at $27.01, underperforming the broader market. The S&P 500 Index dropped 0.18%, and the Dow Jones Industrial Average declined by 0.85%, making it the second consecutive day of losses for Baxter's stock.

Did Envista's Q2 Beat, Guidance Hike and Buybacks Just Shift Envista Holdings' (NVST) Investment Narrative?

Sei Investments Co. Has $4.73 Million Stock Position in Kestra Medical Technologies, Ltd. $KMTS

Sei Investments Co. significantly increased its stake in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) by 22.6% in the first quarter, holding shares valued at approximately $4.73 million. Other major institutions like T. Rowe Price and Franklin Resources also expanded their positions. Despite analyst sentiment being …

Becton, Dickinson beats Q3 2026 earnings and revenue estimates, updates full-year guidance.

Becton, Dickinson and Company (BDX) reported strong Q3 fiscal 2026 results, surpassing analyst expectations with an EPS of $3.23 and revenue of $4.98 billion. The company showed robust financial health, including a 44.6% increase in year-to-date free cash flow, and updated its full-year guidance, …

$1000 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today

An investment of $1000 in Intuitive Surgical (NASDAQ: ISRG) 20 years ago would now be worth $36,616.17, demonstrating the power of compounded returns. The company has outperformed the market with an annualized return of 19.5% over two decades. Intuitive Surgical currently holds a market …

Solventum Announces Intent to Separate its Health Information Systems Business

Solventum (NYSE: SOLV) announced its intent to separate its Health Information Systems business to optimize its portfolio and strengthen its focus as a dedicated MedTech company. This strategic move aims to unlock shareholder value, accelerate innovation, and allow both entities to pursue distinct growth …

Becton Dickinson Lifts Full-Year Profit Outlook as Third-Quarter Results Top Views

Becton Dickinson (BDX) has raised its full-year earnings guidance following strong third-quarter results that surpassed Wall Street expectations. The medical device maker reported revenue gains across all its divisions, leading to an updated adjusted per-share earnings forecast of $12.62 to $12.72 for the year. …

Becton Dickinson and Company (BDX) sits just below fair value before earnings

The medical-technology stock has regained ground across weekly windows, but confirmation remains uneven before the Aug. 6 report.

STAAR Surgical (NASDAQ: STAA) names Warren Foust chief executive

STAAR Surgical has appointed Warren Foust as President and Chief Executive Officer, effective August 4, 2026. Foust previously served as Interim Co-CEO, President, and COO, and his compensation package includes a base salary of $730,000, a significant cash bonus target, and substantial equity grants …

NVST Q2 Deep Dive: Margin Expansion and Product Launches Amid China Market Shifts

Envista Holdings (NYSE:NVST) reported better-than-expected Q2 CY2026 results, with revenue up 7.1% year-on-year to $730.5 million and adjusted EPS beating estimates by 22.1%. The company's performance was driven by balanced growth across geographies, new product launches in endodontics and orthodontics, and margin expansion due …

EMBC Investors Have Opportunity to Lead Embecta Corp. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) and its officers. The lawsuit alleges that Embecta made false and misleading statements about its business and operations, particularly concerning its pen needle business and fiscal guidance, leading …

Bausch + Lomb Corporation

Bausch + Lomb Corporation announced changes to its Board of Directors on August 6, 2026. Following this news, the company's shares (T.BLCO) were trading down by $0.20 at $16.54. This update was reported by Glenn Wilkins.

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 17, 2026 in Embecta Corp. Lawsuit - EMBC

Levi & Korsinsky, LLP is reminding Embecta Corp. (NASDAQ: EMBC) investors of a pending class action lawsuit with a lead plaintiff deadline of August 17, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal year 2026 revenue guidance and U.S. pen …

Teleflex (NYSE:TFX) Issues FY 2026 Earnings Guidance